Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression of gamma-glutamylcysteine synthetase

Free Radical Biology & Medicine
Konjeti R SekharDavid Guis

Abstract

Exposure of HepG2 cells to nonsteroidal anti-inflammatory drugs (i.e., indomethacin and ibuprofen; NSAIDs) as well as resveratrol, caused increased expression of the mRNAs coding for the catalytic (Gclc) and modifier (Gclm) subunits of the glutathione synthetic enzyme, gamma-glutamylcysteine synthetase. In addition, indomethacin exposure increased intracellular glutathione content as well as inhibited glutathione depletion and cytotoxicity caused by diethyl maleate. Indomethacin-induced increases in the expression of gamma-glutamylcysteine synthetase mRNA were preceded by increases in steady state levels of intracellular pro-oxidants and glutathione disulfide accumulation. Simultaneous incubation with the thiol antioxidant N-acetylcysteine (NAC) inhibited indomethacin-mediated increases in GCLC mRNA, suggesting that increases in GCLC message were triggered by changes in intracellular oxidation/reduction (redox) reactions. Indirect immunofluorescence using intact cells demonstrated that indomethacin induced the nuclear translocation of Nrf2, a transcription factor believed to regulate GCLC expression. Immunoprecipitation studies showed that indomethacin treatment also inhibited Nrf2 tethering to KIAA0132 (the human homolog of Ke...Continue Reading

References

May 1, 1988·DNA·P E DanielsonJ G Sutcliffe
May 29, 1997·Biochemical and Biophysical Research Communications·K R SekharM L Freeman
Oct 7, 1997·Cell Stress & Chaperones·M L FreemanJ Lepock
May 8, 1998·Journal of Toxicology and Environmental Health. Part a·J F RebbeorN Ballatori
Aug 4, 1998·Human Reproduction·A LenziM Picardo
Aug 15, 1998·Biochemical and Biophysical Research Communications·M J MeredithM L Freeman
Jan 6, 1999·Seminars in Liver Disease·M E Anderson, J L Luo
Jan 15, 1999·JPEN. Journal of Parenteral and Enteral Nutrition·L R PenaC J McClain
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·K Chan, Y W Kan
Nov 24, 1999·The Journal of Biological Chemistry·A C WildR T Mulcahy
Jan 7, 2000·Journal of Cellular Physiology·S R SoltaninassabM L Freeman
Jan 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·A S KalgutkarL J Marnett
Feb 3, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y IimuroR G Thurman
May 16, 2000·The Journal of Laboratory and Clinical Medicine·C A LangM C Liu
Aug 10, 2000·European Journal of Biochemistry·J B SchulzJ Dichgans
Sep 1, 2000·The American Journal of Clinical Nutrition·J D BogdenD B Louria
Sep 22, 2000·The Biochemical Journal·S P DaviesP Cohen
Oct 18, 2000·Proceedings of the National Academy of Sciences of the United States of America·H C HuangC B Pickett
Nov 4, 2000·Expert Opinion on Investigational Drugs·M HüllB L Fiebich
Dec 1, 2000·Biochemical and Biophysical Research Communications·L M Zipper, R T Mulcahy
Dec 21, 2000·American Journal of Physiology. Heart and Circulatory Physiology·K KugiyamaH Yasue
Jan 10, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·H KamencicB H Juurlink

❮ Previous
Next ❯

Citations

Jan 7, 2004·Biochemical and Biophysical Research Communications·Lucio LagunasDavid Gius
Jul 25, 2003·Biochemical and Biophysical Research Communications·Barbara J BuckleyA R Whorton
Apr 23, 2003·Free Radical Biology & Medicine·Seiko NarushimaDaniel J Berg
Sep 8, 2004·Biochemistry·Leonid BuryanovskyyZhongtao Zhang
Feb 12, 2005·Antioxidants & Redox Signaling·Makoto Kobayashi, Masayuki Yamamoto
Aug 25, 2004·Neurosurgical Focus·Timothy C RykenDaniel K Resnick
Dec 17, 2009·Journal of Cancer Research and Therapeutics·Andrean L SimonsDouglas R Spitz
May 9, 2012·Angewandte Chemie·Tuba EsatbeyogluGerald Rimbach
Apr 2, 2013·Free Radical Biology & Medicine·Jae-woong HwangIrfan Rahman
Jun 14, 2008·Expert Opinion on Investigational Drugs·Danyelle M TownsendKenneth D Tew
Aug 5, 2006·Advances in Enzyme Regulation·Makoto Kobayashi, Masayuki Yamamoto
Jan 23, 2016·Redox Biology·Hiroyuki KanzakiYoshiki Nakamura
May 6, 2009·International Journal of Biological Macromolecules·Zuzana VantováJán Imrich
Apr 25, 2012·Molecular and Cellular Biochemistry·Katarzyna LubelskaKatarzyna Wiktorska
Nov 21, 2002·The Journal of Biological Chemistry·Daniel StewartJawed Alam
Apr 23, 2020·The Journal of Cell Biology·Jay X Tan, Toren Finkel
Jul 22, 2020·Thyroid : Official Journal of the American Thyroid Association·Panos G ZirosGerasimos P Sykiotis
Jul 20, 2007·American Journal of Physiology. Renal Physiology·Mohammad AsgharMustafa F Lokhandwala
Nov 28, 2002·American Journal of Physiology. Renal Physiology·Jawed AlamKarl A Nath
Nov 20, 2018·Journal of Hazardous Materials·Yuta Komoike, Masato Matsuoka
Feb 4, 2010·Toxicology and Applied Pharmacology·Jonathan Maher, Masayuki Yamamoto
Jan 5, 2005·Free Radical Biology & Medicine·Andrei V BakinMichael L Freeman
Oct 15, 2008·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Danyelle M Townsend, Kenneth D Tew

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.